Safety of combining ticlopidine with nadroparin in the routine treatment of chronic hemodialysis patients.
Kamper
A M
AM
Lins
R L
RL
Zachée
P
P
Van Bergen
S
S
Hosten
S
S
Daelemans
R
R
D004338:Drug Combinations; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D017762:Nadroparin / Q000009:adverse effects* / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006435:Renal Dialysis; D013988:Ticlopidine / Q000009:adverse effects* / Q000627:therapeutic use
D004338:Drug Combinations; D017762:Nadroparin; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine